NCT07321574 2026-01-07
ABP1011T-03
Shanghai AB PharmaTech Ltd.
Phase 2 Recruiting
Clinical Trials
10 trialsNCT07308379 2025-12-29
Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer
Fudan University
Not yet recruiting
NCT06812260 2025-09-17
A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC
Shanghai Henlius Biotech
Phase 2 Recruiting
NCT04221529 2025-09-08
SPACE
AIO-Studien-gGmbH
Phase 2 Completed
NCT07141771 2025-08-26
An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Not yet recruiting
NCT06793228 2025-01-27
Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT06620796 2024-10-01
A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Not yet recruiting
NCT06477523 2024-06-27
Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC
Sichuan University
Phase 1/2 Recruiting
NCT05116007 2024-05-31
Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC
Akeso
Phase 1 Completed
NCT05507593 2022-08-19
Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Unknown